An improved system for detecting cancers that uses magnetic rather than radioactive tracers has taken a major step towards commercialisation.

Researchers at the University of South Australia’s Future Industries Institute have joined forces with New Zealand-based nanoparticle specialist Boutiq Science and major IP investor, Powerhouse Ventures.

The new technology – an ultrasensitive magnetometer probe designed to be about the size of a ball-point pen – evolved from the doctoral work of University of South Australia researcher Dr Aidan Cousins who is now overseeing the development of the technology in collaboration with Associate Professor Benjamin Thierry.